PATENT CLAIM ANALYSIS

Application Number: 16013019
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["548", "362100"]

Abstract:
The present invention relates to substituted indazole compounds which modulate the activity of protein kinases and are therefore useful in treating diseases caused by degulated protein kinase activity, like cancer. The present invention also provides methods for preparing these compounds, pharmaceutical compositions comprising these compounds, and methods of treating diseases utilizing such these compounds or the pharmaceutical compositions containing them.

Claim (Index 29):
The compound of formula (I) as defined in  claim 27  wherein:\n Ar is Ar1 or Ar2; and R2, R3, R4, R5 are each independently hydrogen, halogen, NR11R12 or OR13, wherein R11, R12 and R13 are as defined in  claim 27 .

Metadata:
- Claim Count in Document: 20.0
- Percentile: 94.0
- Lexical Diversity: 1.47727
- Patent Class: 548.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15203087', '15203092', '12520387', '13140208', '12668745']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7889349483021877
- 35 USC 102 Novelty (BERT): 0.5790736404088005
- Combined Prediction Score: 0.7679488175128489
- Mean Citation Score: 462.263366
- Max Citation Score: 502.09686
- Similarity Product: 378.5310279834866

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test